섬유 이식물 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the textile implants market was valued at USD 6.60 billion in 2025 and estimated to grow from USD 6.99 billion in 2026 to reach USD 9.53 billion by 2031, at a CAGR of 6.39% during the forecast period 2026-2031.

This report is Segmented by Textile Type (Synthetic Textile Implants, 2D Textile Implants, and Others), Indication (Hernia Repair, Cardiovascular Surgery, and Other Indications), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Textile Implants Market Trends and Insights

Rising Preference for Bioengineered Meshes and Reinforcement Textiles

The textile implants market is seeing a clear move away from legacy polypropylene mesh toward poly-4-hydroxybutyrate, collagen-reinforced, and other bioresorbable textile constructs. This change is not only about surgeon preference, because liability exposure tied to permanent synthetic mesh has also pushed hospitals and suppliers toward newer materials. In 2025, BD received FDA 510(k) clearance for the Phasix ST Umbilical Hernia Patch, which was positioned as the first fully absorbable hernia mesh designed specifically for umbilical repair, showing that scale commercialization is becoming more practical in the textile implants market. Product innovation is also moving beyond absorbability alone, because multifunctional mesh designs now incorporate antimicrobial and anti-adhesive features directly into textile architecture. That broader value proposition matters in the textile implants market because it supports outcome improvement while keeping textile-based reinforcement central to repair strategies. As more evidence builds around these formulations, procurement decisions in the textile implants market are likely to reflect both risk management and clinical performance.

Higher Surgical Volumes in Hernia, Orthopedic, and Cardiovascular Reconstruction

The textile implants market continues to draw its largest procedural demand from hernia repair, and that demand base is set to expand over time. A 2025 study in BMC Gastroenterology projected that global hernia case incidence will rise by 19.7% in absolute terms by 2050, with population growth and aging acting as the main drivers.The textile implants market is also moving up the value chain because growing procedure volumes are increasingly paired with more advanced implant specifications in robotic and laparoscopic settings. That matters because higher-volume surgical pathways are no longer relying only on standard mesh, and premium constructs with tighter stiffness, unfolding, and delivery requirements are gaining ground. Cardiovascular and orthopedic procedures add further support to the textile implants market by widening the number of clinical scenarios where textile architectures remain necessary. The result is a bifurcated textile implants market, where standard synthetic products keep volume in high-throughput settings while advanced textile formats capture stronger pricing in more specialized care pathways.

Stringent Regulatory Approval and Clinical Evidence Requirements

The textile implants market faces rising compliance pressure because implantable products now require stronger post-market follow-up and broader evidence packages than many legacy portfolios were built to support. This is particularly relevant for pelvic floor and related mesh categories, where historical complication patterns have already led to product withdrawals and tighter scrutiny. In the textile implants market, the regulatory burden is heavier for newer silk-based, collagen-based, and 3D knitted constructs because they must show durable in vivo performance before broader adoption can follow. That requirement lengthens development timelines and raises the cost of commercialization, which can slow smaller innovators more than diversified medtech companies. As a result, the textile implants market increasingly rewards manufacturers that already have quality systems, long-term evidence programs, and device traceability infrastructure in place. This does not stop innovation in the textile implants market, but it does raise the threshold for who can scale it efficiently.

Other drivers and restraints analyzed in the detailed report include:

1. Expansion of Outpatient and Ambulatory Surgical Workflows
2. Growing Aging Population and Rising Incidence of Tissue Degeneration Disorders
3. High Cost of Advanced Textile Implant Materials and Procedures

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Synthetic textile implants accounted for a 52.10% share of the textile implants market size in 2025, supported by polypropylene, polyester, and expanded polytetrafluoroethylene constructs that remain widely used across hernia repair, vascular grafting, and soft tissue reinforcement. Their position in the textile implants market reflects long clinical histories, standardized sterilization practices, and broad familiarity among surgeons and procurement teams. For many providers in the textile implants industry, established regulatory pathways and predicate-based product development still favor synthetic variants over newer alternatives. That creates a structural advantage for incumbent suppliers that already serve high-volume repair categories in the textile implants market.

3D textile implants are projected to grow at a 7.19% CAGR from 2026 to 2031 in the textile implants market, because they can provide patient-conforming geometries and controlled pore profiles that flat 2D mesh cannot always achieve in complex reconstructions. Natural textile implants such as silk and collagen variants remain smaller in volume, but the textile implants market is seeing stronger research and clinical interest in applications where tissue integration matters more than simple cost comparison. The textile implants market is therefore moving toward a broader mix where synthetic products keep the base and advanced architectures drive the next layer of value creation.

Complete Report Scope:

• By Textile Type
  • Synthetic Textile Implants
  • 2D Textile Implants
  • 3D Textile Implants
  • Hybrid Textile Implants
  • Natural Textile Implants
  • Collagen-Based Textile Implants
  • Silk-Based Textile Implants
• By Indication
  • Hernia Repair
  • Cardiovascular Surgery
  • Orthopedic Surgery
  • Dental Grafts
  • Soft Tissue Reconstruction
  • Pelvic Floor Repair
  • Other Indications
• By End-User
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Specialty Surgical Centers
  • Other End-Users
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 46.80% of the textile implants market share in 2025, supported by high procedure volumes, mature reimbursement systems, and a dense installed base of advanced surgical platforms. The United States remains the main revenue driver in the textile implants market across hernia mesh, vascular grafts, and orthopedic textile scaffolds. The region also benefits from established commercialization pathways and broad clinical familiarity with synthetic as well as premium reinforcement options. In the textile implants market, this creates a favorable setting for suppliers that can serve both high-volume routine repair and higher-value specialized reconstruction. Europe also holds a substantial position in the textile implants market, supported by strong specialist surgical infrastructure and steady demand across Germany, the United Kingdom, France, Italy, and Spain.

Asia-Pacific textile implants market is projected to expand at an 8.22% CAGR between 2026 and 2031, making it the fastest-growing geography in the textile implants market. Growth in the region is being supported by expanding surgical capacity in China, India, South Korea, and Australia, along with rising chronic disease prevalence that increases hernia and cardiovascular procedure volumes. The textile implants market in Asia-Pacific is also gaining from a growing orthopedic reconstruction base, which broadens the need for woven and braided implant formats. Japan adds a premium demand layer to the textile implants market because its older population supports steady use in cardiovascular and orthopedic procedures. India and South Korea are also strengthening their positions in the textile implants market through medical tourism inflows and healthcare infrastructure investment that widens access to both standard and advanced implant categories.

The Middle East and Africa remain smaller in the textile implants market, but private hospital investment in GCC countries is improving tertiary surgical capacity and opening space for premium implant formats. South Africa continues to anchor sub-Saharan demand in the textile implants market through its private healthcare network, although public procurement is still highly cost-sensitive. South America is led by Brazil and Argentina in the textile implants market, with hernia repair remaining the main clinical use and hospital-based procedures accounting for most implant consumption. A gradual increase in laparoscopic capability across secondary cities could still expand the reachable base for standard textile implants market products beyond what demographics alone would suggest. Overall, the textile implants market shows a clear split between mature high-value regions and faster-growing markets where infrastructure expansion is driving the next wave of adoption.

1. Aran Biomedical Teoranta
2. B. Braun
3. Beckton Dickinson
4. Boston Scientific
5. Coloplast
6. Conmed
7. Cook Group
8. Corza Medical
9. Cousin Biotech
10. Integra LifeSciences
11. Johnson & Johnson
12. Medtronic
13. Serag-Wiessner GmbH and Co. KG
14. Smiths Group
15. Stryker
16. TELA Bio, Inc.
17. Teleflex
18. Titanium Textiles AG
19. W. L. Gore and Associates, Inc.
20. Zimmer Biomet

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Preference for Bioengineered Meshes and Reinforcement Textiles
  • 4.2.2 Higher Surgical Volumes in Hernia, Orthopedic, and Cardiovascular Reconstruction
  • 4.2.3 Improved Clinical Adoption of Resorbable and Hybrid Textile Implants
  • 4.2.4 Expansion of Outpatient and Ambulatory Surgical Workflows
  • 4.2.5 Advancements in Biomaterial Engineering and Smart Textile Technologies
  • 4.2.6 Growing Aging Population and Rising Incidence of Tissue Degeneration Disorders
• 4.3 Market Restraints
  • 4.3.1 Stringent Regulatory Approval and Clinical Evidence Requirements
  • 4.3.2 Procedure and Device-Related Complication Risk
  • 4.3.3 High Cost of Advanced Textile Implant Materials and Procedures
  • 4.3.4 Risk of Post-Surgical Infections and Foreign Body Reactions
• 4.4 Supply Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Textile Type
  • 5.1.1 Synthetic Textile Implants
  • 5.1.2 2D Textile Implants
  • 5.1.3 3D Textile Implants
  • 5.1.4 Hybrid Textile Implants
  • 5.1.5 Natural Textile Implants
  • 5.1.6 Collagen-Based Textile Implants
  • 5.1.7 Silk-Based Textile Implants
• 5.2 By Indication
  • 5.2.1 Hernia Repair
  • 5.2.2 Cardiovascular Surgery
  • 5.2.3 Orthopedic Surgery
  • 5.2.4 Dental Grafts
  • 5.2.5 Soft Tissue Reconstruction
  • 5.2.6 Pelvic Floor Repair
  • 5.2.7 Other Indications
• 5.3 By End-User
  • 5.3.1 Hospitals and Clinics
  • 5.3.2 Ambulatory Surgical Centers
  • 5.3.3 Specialty Surgical Centers
  • 5.3.4 Other End-Users
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, Recent Developments)
  • 6.3.1 Aran Biomedical Teoranta
  • 6.3.2 B. Braun Melsungen AG
  • 6.3.3 BD (Becton Dickinson and Company)
  • 6.3.4 Boston Scientific Corporation
  • 6.3.5 Coloplast Group
  • 6.3.6 Conmed Corporation
  • 6.3.7 Cook Medical LLC
  • 6.3.8 Corza Medical
  • 6.3.9 Cousin Biotech
  • 6.3.10 Integra LifeSciences Holdings Corporation
  • 6.3.11 Johnson and Johnson
  • 6.3.12 Medtronic plc
  • 6.3.13 Serag-Wiessner GmbH and Co. KG
  • 6.3.14 Smith and Nephew plc
  • 6.3.15 Stryker Corporation
  • 6.3.16 TELA Bio, Inc.
  • 6.3.17 Teleflex Incorporated
  • 6.3.18 Titanium Textiles AG
  • 6.3.19 W. L. Gore and Associates, Inc.
  • 6.3.20 Zimmer Biomet Holdings, Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment